Leaflet: Information for the user
Diclofenaco Kern Pharma 11.6 mg/g gel
Diclofenac diethylammonium
Read this leaflet carefully before you start using this medicinebecause it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this leaflet or those indicated by your doctor or pharmacist.
The active ingredient diclofenac dietilamine, belongs to the group of non-steroidal anti-inflammatory drugs and acts as a local analgesic and anti-inflammatory.
Diclofenaco Kern Pharma is indicated in adults and adolescents over 14 years old for local relief of mild and occasional pain and inflammation caused by:
Consult a doctor if it worsens or does not improve after 7 days.
If you think you may be allergic, consult your doctor.
Consult your doctor or pharmacist before starting to use Diclofenaco Kern Pharma.
Children and adolescents
This medication is not recommended for use in children and adolescents under 14 years old, due to insufficient data on safety and efficacy.
Use in elderly patients
Diclofenaco Kern Pharma may be used in patients over 65 years old.
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Do not use Diclofenaco Kern Pharma if you are in the last 3 months of pregnancy. Do not use Diclofenaco Kern Pharma during the first 6 months of pregnancy, unless it is strictly necessary and recommended by your doctor. If you need treatment during this period, you should take the minimum dose possible for the shortest time possible.The oral formulations (e.g., tablets) of diclofenac may cause adverse reactions to the fetus. It is unknown if this same risk applies to Diclofenaco Kern Pharma when used on the skin.
Breastfeeding
Consult your doctor or pharmacist before using any medication.
Do not use Diclofenaco Kern Pharma during breastfeeding, except as directed by your doctor.
Do not apply directly to the breast area.
Driving and operating machinery
No effects on the ability to drive vehicles and use machinery have been described when using Diclofenaco Kern Pharma externally on the skin.
Diclofenaco Kern Pharma contains propylene glycol (E-1520)
This medication contains 50 mg of propylene glycol in each gram of gel.
This medication is for application on the skin (cutaneous use).
The recommended dose is:
Adults and adolescents over 14 years old
Apply 3 or 4 times a day a small amount of gel on the inflamed or painful area.
The amount of gel will vary depending on the size of the affected area (usually, it will be sufficient to apply an amount similar to the size of a cherry or a walnut).
Use in childrenand adolescents under 14 years old
This medication is not recommended for use in children and adolescents under 14 years old, due to insufficient available data on safety and efficacy.
Method of use:
If the pain or swelling worsen or persist after 7 days of treatment, consult your doctor.
If you use more Diclofenaco Kern Pharma than you should
If you accidentally ingest Diclofenaco Kern Pharmaor if you have used it on a large area of the skin and fora long period of time, you may experience adverse reactions similar to those produced bydiclofenac when taken orally (e.g. tablets).
The main symptoms of overdose are: gastrointestinal or renal disorders and difficulty breathing, you may also experience: nausea, vomiting, abdominal pain and decreased level of consciousness.
If you have applied too much of the medication, it is recommended to remove it by washing the affected area with plenty of water, or by removing a part.
In case of accidental ingestion, go immediately to a medical center or call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the amount ingested.
If you forgot to use Diclofenaco Kern Pharma
If you forgot to apply this medication when it was due, apply the gel as soon as possible and continue with the treatment as normal.
Do not apply a double dose to compensate for the missed doses.
If you interrupt the treatment withDiclofenaco Kern Pharma
If you have any other doubts about the use of this product, ask your doctor or pharmacist.
Some rare and very rare adverse effects may be severe.
If you experience any of the following signs of allergy, stop using Diclofenaco Kern Pharma and consult your doctor or pharmacist immediately:
Mild Adverse Effects:
Other adverse effects may occur, but these are usually mild and of short duration. If you notice any of them, consult your doctor or pharmacist as soon as possible.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano https://www.notificaram.es.By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above30°C.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Once opened, discard the tube with the remaining gel after 12 months.
Medications should not be disposed of through drains or in the trash. Deposit the packaging and medications you no longer need at the SIGRE collection pointat the pharmacy.If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Diclofenaco Kern Pharma 11.6 mg/g
Appearance of the product and contents of the packaging
Diclofenaco Kern Pharma 11.6 mg/g gel is a viscous and white gel. It is packaged in an aluminum tube with a screw cap.
The medicine is presented in a tube with 60 and 100 grams of gel.
Only some sizes of packaging may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Kern Pharma, S.L.
Venus, 72 - Pol. Ind.Colón II
08228 Terrassa - Barcelona
Spain
Last review date of this leaflet:May 2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.